vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and iQIYI, Inc. (IQ). Click either name above to swap in a different company.

iQIYI, Inc. is the larger business by last-quarter revenue ($971.6M vs $487.7M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

iQIYI, formerly Qiyi, is a Chinese subscription video on-demand over-the-top streaming service owned by Baidu. Headquartered in Beijing, iQIYI primarily produces and distributes films and television series.

CLOV vs IQ — Head-to-Head

Bigger by revenue
IQ
IQ
2.0× larger
IQ
$971.6M
$487.7M
CLOV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
IQ
IQ
Revenue
$487.7M
$971.6M
Net Profit
$-49.3M
Gross Margin
Operating Margin
-10.1%
0.8%
Net Margin
-10.1%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
IQ
IQ
Q1 26
$971.6M
Q4 25
$487.7M
Q3 25
$496.6M
Q2 25
$477.6M
Q1 25
$462.3M
$906.0M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
Net Profit
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Gross Margin
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
IQ
IQ
Q1 26
0.8%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
4.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Net Margin
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
IQ
IQ
Cash + ST InvestmentsLiquidity on hand
$78.3M
$4.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$13.3M
Total Assets
$541.0M
$46.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
IQ
IQ
Q1 26
$4.4M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
$3.5M
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Stockholders' Equity
CLOV
CLOV
IQ
IQ
Q1 26
$13.3M
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
Q1 25
$336.1M
$13.4M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Total Assets
CLOV
CLOV
IQ
IQ
Q1 26
$46.7M
Q4 25
$541.0M
Q3 25
$559.7M
Q2 25
$575.0M
Q1 25
$583.7M
$45.8M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
IQ
IQ
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
$-66.9M
Q3 25
$12.1M
Q2 25
$5.4M
Q1 25
$-16.3M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
Free Cash Flow
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
FCF Margin
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Capex Intensity
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Cash Conversion
CLOV
CLOV
IQ
IQ
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons